Skip to main content

U of A team develops new antiviral agents to treat COVID-19

An electron microscopic image that shows SARS-CoV-2, the virus that causes COVID-19. (AFP) An electron microscopic image that shows SARS-CoV-2, the virus that causes COVID-19. (AFP)
Share
Edmonton -

A team of University of Alberta researchers has uncovered new antiviral agents that they claim could help treat COVID-19.

The research was published in the Journal of Medicinal Chemistry.

The team found that the antiviral agents interfered with the virus that causes COVID-19’s ability to replicate itself.

“We want to ensure that the drugs being developed will also work with variants of concern and variants of interest, including those identified here in Alberta,” said principal investigator Joanne Lemieux.

Lemieux hopes to develop a treatment that could be taken as a pill, as opposed to a drug that can only be injected intravenously in hospital.

“It’s an exciting time for antiviral drug development,” Lemieux said. 

CTVNews.ca Top Stories

Barron Trump declines to serve as an RNC delegate

Former U.S. President Donald Trump's youngest son, Barron Trump, has declined to serve as a delegate at this summer’s Republican National Convention, according to a senior Trump campaign adviser and a statement from Melania Trump's office.

Stay Connected